Novel discovery may lead to improved oral anti-diabetic drugsJune 16th, 2009 - 4:45 pm ICT by ANI
Washington, June 16 (ANI): Scientists from Hebrew University of Jerusalem claim to have identified a potential target that would help in development of novel oral drugs to control blood glucose levels in diabetes patients.
Lead researcher Prof. Shlomo Sasson of the Hebrew University School of Pharmacy has identified a molecular mechanism that regulates glucose transport in skeletal muscles.
During the study, researchers found that high levels of the carbohydrate D-xylose increased the rate of glucose entry into skeletal muscle cells in a non-insulin-dependent manner.
They then used it as a prototype molecule for the planning and synthesis of chemical derivatives that may act as potential drugs to lower blood glucose in type 2 diabetic patients.
Some of these derivatives increased significantly the rate of glucose transport in skeletal muscles at very low concentrations.
This effect was not achieved by mimicking the classical pathway of insulin action, but by activating the enzyme AMP-activated protein kinase (AMPK).
When activated, this enzyme increases the rate of glucose transport in skeletal muscles in the absence of insulin.
Therefore, compounds that activate this enzyme can be effective in insulin resistant type 2 diabetic patients or in those that fail to respond to conventional drug therapy.
This makes AMPK an extremely attractive target in the development of novel anti-diabetic drugs. (ANI)
- Micro-RNA that regulates insulin in obesity identified - Apr 01, 2011
- Ginger could help control diabetes - Aug 07, 2012
- Eating grapefruit could help treat diabetes - Aug 26, 2010
- Diabetes, obesity drugs may help treat hepatitis C - Jun 08, 2010
- Pair of liver molecules could control diabetes - Apr 09, 2012
- Missing gene turns you into couch potato - Sep 06, 2011
- Popular diabetes drug may help treat cancer - May 05, 2010
- Brain insulin plays critical role in development of diabetes - Feb 17, 2011
- Could red wine treat diabetes? - Nov 20, 2010
- Fat, not sugar, contributes to Type-2 diabetes - Sep 04, 2012
- Bones may have bigger role in diabetes than believed - Jul 23, 2010
- Diabetes linked to schizophrenia - Jun 09, 2010
- World's smallest insulin injection needle launched - May 25, 2011
- Exenatide - a physiological option for a pathological disease. - Sep 17, 2009
- Scientists uncover potential 'cure' for type 1 diabetes - Jan 27, 2011
Tags: attractive target, blood glucose levels, chemical derivatives, conventional drug therapy, dependent manner, diabetes patients, diabetic drugs, diabetic patients, glucose transport, hebrew university of jerusalem, insulin action, molecular mechanism, oral drugs, sasson, school of pharmacy, shlomo, skeletal muscle cells, skeletal muscles, study researchers, xylose